Phase II/III Study Comparing Chemoradiotherapy With Radiotherapy in Elderly Patients With Esophageal or Esophagogastric Cancer - 3JECROG P-01

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

350

Participants

Timeline

Start Date

October 31, 2016

Primary Completion Date

April 30, 2020

Study Completion Date

April 30, 2020

Conditions
Esophagus CancerEsophagogastric Junction CancerRadiotherapy; ComplicationsChemoradiation
Interventions
RADIATION

SIB-IMRT

DRUG

S-1

Trial Locations (1)

100021

Department of Radiation Oncology, Cancer Hospital, National Cancer Center, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC), Beijing

All Listed Sponsors
collaborator

Hebei Medical University Fourth Hospital

OTHER

collaborator

Tianjin Medical University Cancer Institute and Hospital

OTHER

collaborator

Anyang Tumor Hospital

OTHER

collaborator

The First Affiliated Hospital with Nanjing Medical University

OTHER

collaborator

Affiliated Hospital of Hebei University

OTHER

collaborator

Fujian Cancer Hospital

OTHER_GOV

collaborator

Tengzhou Central People's Hospital

OTHER_GOV

collaborator

The First Affiliated Hospital of Zhengzhou University

OTHER

collaborator

The Affiliated Hospital of Inner Mongolia Medical University

OTHER

collaborator

Sichuan Cancer Hospital and Research Institute

OTHER

lead

Chinese Academy of Medical Sciences

OTHER

NCT02979691 - Phase II/III Study Comparing Chemoradiotherapy With Radiotherapy in Elderly Patients With Esophageal or Esophagogastric Cancer - 3JECROG P-01 | Biotech Hunter | Biotech Hunter